Disease modifying therapies in multiple sclerosis

被引：2
|
作者：
Khatri, BO
McQuillen, MP
机构：
来源：
NEUROLOGY | 2002年 / 59卷 / 03期
关键词：
D O I：
10.1212/WNL.59.3.471
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [41] Inequalities in the provisions of disease modifying therapies for multiple sclerosis in the UK
    Evangelou, N.
    Karsay, A.
    Owens, T.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (12): : 1399 - 1399
  • [42] Impact of Disease-Modifying Therapies on Fatigue in Multiple Sclerosis
    Voelter, H. U.
    Hildebrandt, H.
    Kastrup, A.
    AKTUELLE NEUROLOGIE, 2016, 43 (08) : 511 - 518
  • [43] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Benedikt Kretzschmar
    Hannah Pellkofer
    Martin S. Weber
    Current Neurology and Neuroscience Reports, 2016, 16
  • [44] Current and future disease-modifying therapies in multiple sclerosis
    Lim, S. Y.
    Constantinescu, C. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 637 - 650
  • [45] Disease-modifying therapies and infectious risks in multiple sclerosis
    Winkelmann, Alexander
    Loebermann, Micha
    Reisinger, Emil C.
    Hartung, Hans-Peter
    Zettl, Uwe K.
    NATURE REVIEWS NEUROLOGY, 2016, 12 (04) : 217 - 233
  • [46] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [47] Regulation of human glia by multiple sclerosis disease modifying therapies
    Luke M. Healy
    Mackenzie A. Michell-Robinson
    Jack P. Antel
    Seminars in Immunopathology, 2015, 37 : 639 - 649
  • [48] Tuberculosis screening in the setting of multiple sclerosis disease modifying therapies
    Baldassari, L.
    Willis, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 937 - 938
  • [49] Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
    Lee, Chi-Yan
    Chan, Koon-Ho
    PHARMACEUTICS, 2024, 16 (01)
  • [50] Disease-modifying therapies and infectious risks in multiple sclerosis
    Alexander Winkelmann
    Micha Loebermann
    Emil C. Reisinger
    Hans-Peter Hartung
    Uwe K. Zettl
    Nature Reviews Neurology, 2016, 12 : 217 - 233
12345